| |
| > |
Publications
- Zobel, H. P., Kreuter, J.,
Werner, D., Noe, C. R., Kümel,
G., and Zimmer, A.; Cationic
polyhexylcyanoacrylate nanoparticles
as carriers for antisense
oligo-nucleotides. Antisense
Nucl. Acid Drug Devel. 1997,
7: 483 - 493.
- Reiss, S., von Briesen,
H., Rübsamen-Waigmann,
H., Kreuter, J., and Langer,
K.; Human serum albumin-derived
nanoparticles for gene delivery.
J. Controlled Rel. 2003, 92:
199 - 208.
- Löbenberg, R. and Kreuter,
J.; Macrophage targeting of
azidothymidine: A promising
strategy for AIDS therapy.
AIDS Res. Human Retrovir.
1996, 12: 1709 - 1715.
- Bender, A. R., von Briesen,
H., Kreuter, J., Duncan, I.
B., and Rübsamen-Waigmann,
H.; Efficiency of nano-particles
as a carrier system for antiviral
agents in human immunodificiency
virus-infected human monocytes
/ macrophages in vitro. Antimicrob.
Agents Chemother. 1996, 40:
1467 - 1471.
- Kreuter, J., Alyautdin,
R. N., Kharkevich, D. A.,
and Ivanov, A. A.; Passage
of peptides through the blood-brain
barrier with colloidal polymer
particles (nanoparticles).
Brain Res. 1995, 674: 171
- 174.
- Gulyaev, A. E., Gelperina,
S. E., Skidan, I. N., Antropov,
A. S., Kivman, G. Ya., and
Kreuter, J.; Significant transport
of doxorubicin into the brain
with polysorbate 80-coated
nanoparticles. Pharm. Res.
1999, 16: 1564 – 1569.
- Friese, A., Seiller, E.,
Quack, G., Lorenz, B., and
Kreuter, J.; Increase of the
duration of the anticonvulsive
activity of a novel NMDA receptor
antagonist using poly(butylcyanoacylate)
nanoparticles as a parenteral
controlled release system.
Eur. J. Pharm. Biopharm. 2000,
49: 103 -109.
- Kreuter, J., Shamenkov,
D., Petrov, V., Ramge, P.,
Cychutek, K., Koch-Brandt,
C., and Alyautdin, R.; Apolipoprotein-mediated
transport of nanoparticle-bound
drugs across the blood-brain
barrier. J. Drug. Target.
2002, 10: 317 - 325.
- Steiniger, S. C. J., Kreuter,
J., Khalansky, A. S., Skidan,
I. N., Bobruskin, A. I., Smirnova,
Z. S., Severin, S. E., Uhl,
R., Kock, M., Geiger, K. D.,
and Gelperina, S. E.; Chemotherapy
of glioblastoma in rats using
doxorubicin-loaded nanoparticles.
Int. J. Cancer 2004, 109:
759 - 767.
- Selzer, T., Radau, M., and
Kreuter, J.; Use of isothermal
heat conduction microcalorimetry
to evaluate stability and
excipient compatibility of
a solid drug. Int. J. Pharm.
1998, 17: 227 - 241.
- Latsch, S., Selzer, T.,
Fink, L., and Kreuter, J.;
Crystallisation of estradiol
containing TDDS determined
by isothermal microcalorimetry,
X-ray diffraction, and optical
microscopy. Eur. J. Pharm.
Biopharm. 2003, 56: 43 - 52.
|
|
